10/20/2026
Psychedelics fast-tracked by FDA under Trump order
Executive order allocates $50 million for psychedelic drug development, including ibogaine.
Topic archive
2 stories
10/20/2026
Executive order allocates $50 million for psychedelic drug development, including ibogaine.
9/14/2026
Deborah Kadagian founded the Solas Foundation to expand ibogaine access.